<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00660413</url>
  </required_header>
  <id_info>
    <org_study_id>AMG-MMG D-R</org_study_id>
    <nct_id>NCT00660413</nct_id>
  </id_info>
  <brief_title>Comparison of Acceleromyography (AMG) and Mechanomyography (MMG) for Establishing Potency of Neuromuscular Blocking Agents</brief_title>
  <official_title>Comparison of Acceleromyography and Mechanomyography for Establishing Potency of Neuromuscular Blocking Agents, A Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study was to compare two methods for neuromuscular monitoring,
      acceleromyography and mechanomyography for establishing the dose-response relationship and
      the potency of a neuromuscular blocking agent using rocuronium as an example. We hypothesized
      that there would be no significant difference between potencies estimated using
      acceleromyography and mechanomyography.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2007</start_date>
  <completion_date type="Actual">February 2008</completion_date>
  <primary_completion_date type="Actual">February 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of ED50 with the two methods</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparison of ED95 with the two methods</measure>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Neuromuscular Blockade</condition>
  <arm_group>
    <arm_group_label>AMG</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Acceleromygraphy monitoring</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MMG</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Mechanomyography monitoring</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TOF-Watch SX (Acceleromyography)</intervention_name>
    <description>Randomization of AMG to dominant or non-dominant arm. MMG at contralateral arm.</description>
    <arm_group_label>AMG</arm_group_label>
    <arm_group_label>MMG</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA I-III

          -  Ideal weight +/-20%

          -  Both arms available for neuromuscular monitoring

          -  Surgery in supine position

          -  Participated surgery time more than 30 min

        Exclusion Criteria:

          -  Pregnant and breast-feeding women

          -  Patients with known illness or use of medications known to influence the neuromuscular
             transmission

          -  Known significant renal or hepatic dysfunction

          -  Allergy to medications used in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Casper Claudius, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <state>Ã˜sterbro</state>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>April 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 15, 2008</study_first_submitted>
  <study_first_submitted_qc>April 15, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 17, 2008</study_first_posted>
  <last_update_submitted>April 15, 2008</last_update_submitted>
  <last_update_submitted_qc>April 15, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 17, 2008</last_update_posted>
  <keyword>Acceleromyography</keyword>
  <keyword>Mechanomyography</keyword>
  <keyword>Neuromuscular block</keyword>
  <keyword>Neuromuscular monitoring</keyword>
  <keyword>Dose-response</keyword>
  <keyword>Potency</keyword>
  <keyword>Rocuronium</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neuromuscular Blocking Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

